Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response Document date: 2020_4_14
ID: d7stppv5_3
Snippet: Here we use mathematical models to project the possible impact of two small molecular agents, remdesivir and hydroxychloroquine; as well as broadly neutralizing antibodies and cellular immunotherapies. The goal of our models is to interpret emerging clinical trial data, and in turn to perfect subsequent trials in terms of selection of antiviral agents, timing of therapy, dosage, treatment duration, avoidance of drug resistance and selection of vi.....
Document: Here we use mathematical models to project the possible impact of two small molecular agents, remdesivir and hydroxychloroquine; as well as broadly neutralizing antibodies and cellular immunotherapies. The goal of our models is to interpret emerging clinical trial data, and in turn to perfect subsequent trials in terms of selection of antiviral agents, timing of therapy, dosage, treatment duration, avoidance of drug resistance and selection of virologic endpoints. Overall, our simulations support initiation of therapy soon after symptoms develop and also suggest the urgent need for studies to identify virologic surrogates of SARS CoV-2 severity.
Search related documents:
Co phrase search for related documents- possible impact and treatment duration: 1, 2
- possible impact and urgent need: 1, 2, 3, 4, 5, 6, 7
- SARS severity and therapy initiation: 1
- SARS severity and treatment duration: 1, 2
- SARS severity and urgent need: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- symptom develop and urgent need: 1
- therapy initiation and treatment duration: 1, 2, 3
- therapy initiation and urgent need: 1, 2, 3, 4, 5
- treatment duration and urgent need: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date